MedPath
FDA Approval

Hydrocodone Bitartrate and Homatropine Methylbromide

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 7, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Hydrocodone(5 mg in 5 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

ATLANTIC BIOLOGICALS CORP.

ATLANTIC BIOLOGICALS CORP.

047437707

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydrocodone Bitartrate and Homatropine Methylbromide

Product Details

NDC Product Code
17856-0455
Application Number
ANDA088008
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
April 7, 2021
Code: NO70W886KKClass: ACTIBQuantity: 5 mg in 5 mL
Code: 68JRS2HC1CClass: ACTIBQuantity: 1.5 mg in 5 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
SUCROSEInactive
Code: C151H8M554Class: IACT
GLYCERINInactive
Code: PDC6A3C0OXClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OHClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
D&C RED NO. 33Inactive
Code: 9DBA0SBB0LClass: IACT
CARAMELInactive
Code: T9D99G2B1RClass: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSLClass: IACT
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95KClass: IACT
© Copyright 2025. All Rights Reserved by MedPath